Total Health
Avatar

ASCO 2022 Non-Colorectal Cancer Updates

By Total Health FEATURING Daniel Catenacci
By Total Health FEATURING Daniel Catenacci
487 views
July 12, 2022
1 Comment
Login to view comments. Click here to Login

Featured Video

10:25
Exelixis

Explore the mechanism of Action of a TKI in HCC

Feat. W. Keiser

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Related Content

AUTOPLAY
57:44
Vogl, NY

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl
27:37
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini
23:58
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Key Studies

Feat. R. Kim, R. Mehta
20:07
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials I…

Feat. Y. Janjigian, S. Cytryn, S. Maron
08:34
Yale Cancer Center

NORPACT-1 Trial Updates: Neoadjuvant FOLFIRINOX vs. Upfront Surgery …

Feat. J. Lacy
27:12
Moffitt Cancer Center

Year in Review: Upper GI Cancers

Feat. R. Kim, R. Mehta
06:47
UCSF School of Medicine

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…

Feat. H. Kang
07:35
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Summary: "Gastro-Esophageal Key Studies Including…

Feat. R. Kim, R. Mehta
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
09:42
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Panel Discussion: "MATTERHORN & KEYNOTE-585 C…

Feat. Y. Janjigian, S. Cytryn, S. Klempner
23:27
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "GI Key Studies Including MATTERHORN & K…

Feat. R. Kim, R. Mehta
24:56
Florida Gastroenterologic Society

Neuroendocrine Tumors in the GI Tract

Feat. A. Luthra
07:27
Jason Levy

Opus One: Final Results - RFA in Axial Skeleton

19:41
Balazs Halmos

How I Manage Immune Adverse Events in Solid Tumors

17:23
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Summary: "Esophageal Squamous Cell Carcinoma Key …

Feat. R. Kim, R. Mehta
13:47
Sakti Chakrabarti

Neoadjuvant IO in MSI-High GI Cancers: Special Focus on the DREAM GI…

Feat. A. Shreenivas
06:03
Total Health

2024 Updates on Targeted Approaches for GI Cancers and New Data in N…

Feat. A. Grothey
09:01
Integrity Continuing Education

Debates in Neoadjuvant Therapy in Resectable Pancreatic Cancer: Why …

Feat. L. Zheng
03:50
UCLA Health

Perspectives on the Recent FDA Approval of NALIRIFOX in Frontline Me…

Feat. Z. Wainberg
18:51
Hope for Stomach Cancer

1L Therapy for Stage 4 Gastroesophageal Cancers: The Role of Biomark…

Feat. D. Catenacci